S 1645
ADAPT Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the ADAPT Act, aims to speed up the drug approval process in the United States for medications already approved in other countries. It allows the Food and Drug Administration (FDA) to expedite reviews of drugs that are marketed in nations like Australia, Canada, and Japan, provided they meet specific criteria regarding safety, effectiveness, and unmet medical needs. The FDA must review and decide on applications within 180 days of submission, potentially with requirements for post-approval studies and marketing material oversight.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Mike Braun
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.